Dahiya M, Yadav M, Goyal C, Kumar A
Inflammopharmacology. 2025; .
PMID: 40064805
DOI: 10.1007/s10787-025-01704-2.
Maisto N, Mango D
J Pharm Anal. 2025; 14(12):101057.
PMID: 39802402
PMC: 11718335.
DOI: 10.1016/j.jpha.2024.101057.
Zhang Q, Hu S, Jin Z, Wang S, Zhang B, Zhao L
Front Pharmacol. 2024; 15:1339148.
PMID: 38510656
PMC: 10953506.
DOI: 10.3389/fphar.2024.1339148.
Smith K, Fan J, Marriner G, Gerdes J, Kessler R, Zinn K
Alzheimers Dement (N Y). 2024; 10(1):e12459.
PMID: 38469552
PMC: 10925727.
DOI: 10.1002/trc2.12459.
Jamshidnejad-Tosaramandani T, Kashanian S, Karimi I, Schioth H
Polymers (Basel). 2024; 16(4).
PMID: 38399888
PMC: 10891873.
DOI: 10.3390/polym16040510.
Schisandrin A Alleviates Spatial Learning and Memory Impairment in Diabetic Rats by Inhibiting Inflammatory Response and Through Modulation of the PI3K/AKT Pathway.
Guo X, Lei M, Ma G, Ouyang C, Yang X, Liu C
Mol Neurobiol. 2023; 61(5):2514-2529.
PMID: 37910285
DOI: 10.1007/s12035-023-03725-w.
Tirzepatide ameliorates spatial learning and memory impairment through modulation of aberrant insulin resistance and inflammation response in diabetic rats.
Guo X, Lei M, Zhao J, Wu M, Ren Z, Yang X
Front Pharmacol. 2023; 14:1146960.
PMID: 37701028
PMC: 10493299.
DOI: 10.3389/fphar.2023.1146960.
Intranasal insulin treatment partially corrects the altered gene expression profile in the hippocampus of developing rats with perinatal iron deficiency.
Sandri B, Ennis-Czerniak K, Kanajam P, Frey 2nd W, Lock E, Rao R
Am J Physiol Regul Integr Comp Physiol. 2023; 325(4):R423-R432.
PMID: 37602386
PMC: 10639019.
DOI: 10.1152/ajpregu.00311.2022.
Sex differences in metabolic phenotype and hypothalamic inflammation in the 3xTg-AD mouse model of Alzheimer's disease.
Robison L, Gannon O, Salinero A, Abi-Ghanem C, Kelly R, Riccio D
Biol Sex Differ. 2023; 14(1):51.
PMID: 37559092
PMC: 10410820.
DOI: 10.1186/s13293-023-00536-5.
Outcomes and clinical implications of intranasal insulin on cognition in humans: A systematic review and meta-analysis.
Wu S, Stogios N, Hahn M, Navagnanavel J, Emami Z, Chintoh A
PLoS One. 2023; 18(6):e0286887.
PMID: 37379265
PMC: 10306194.
DOI: 10.1371/journal.pone.0286887.
Integrated transcriptome and metabolome analysis to investigate the mechanism of intranasal insulin treatment in a rat model of vascular dementia.
Tang L, Wang Y, Gong X, Xiang J, Zhang Y, Xiang Q
Front Pharmacol. 2023; 14:1182803.
PMID: 37256231
PMC: 10225696.
DOI: 10.3389/fphar.2023.1182803.
Selective breeding for physical inactivity produces cognitive deficits altered hippocampal mitochondrial and synaptic function.
Kerr N, Kelty T, Mao X, Childs T, Kline D, Rector R
Front Aging Neurosci. 2023; 15:1147420.
PMID: 37077501
PMC: 10106691.
DOI: 10.3389/fnagi.2023.1147420.
Type 2 Diabetes Mellitus and Alzheimer's Disease: Shared Molecular Mechanisms and Potential Common Therapeutic Targets.
Hamze R, Delangre E, Tolu S, Moreau M, Janel N, Bailbe D
Int J Mol Sci. 2022; 23(23).
PMID: 36499613
PMC: 9739879.
DOI: 10.3390/ijms232315287.
Efficacy of intranasal insulin in improving cognition in mild cognitive impairment or dementia: a systematic review and meta-analysis.
Long C, Han X, Yang Y, Li T, Zhou Q, Chen Q
Front Aging Neurosci. 2022; 14:963933.
PMID: 36172480
PMC: 9512636.
DOI: 10.3389/fnagi.2022.963933.
Intranasal Insulin Attenuates the Long-Term Adverse Effects of Neonatal Hyperglycemia on the Hippocampus in Rats.
McClure Yauch L, Ennis-Czerniak K, Frey Ii W, Tkac I, Rao R
Dev Neurosci. 2022; 44(6):590-602.
PMID: 36041414
PMC: 9928603.
DOI: 10.1159/000526627.
A novel bio-inspired strategy to prevent amyloidogenesis and synaptic damage in Alzheimer's disease.
Catania M, Colombo L, Sorrentino S, Cagnotto A, Lucchetti J, Barbagallo M
Mol Psychiatry. 2022; 27(12):5227-5234.
PMID: 36028569
PMC: 9763104.
DOI: 10.1038/s41380-022-01745-x.
Insulin receptor activation by proinsulin preserves synapses and vision in retinitis pigmentosa.
Sanchez-Cruz A, Hernandez-Pinto A, Lillo C, Isiegas C, Marchena M, Lizasoain I
Cell Death Dis. 2022; 13(4):383.
PMID: 35444190
PMC: 9021205.
DOI: 10.1038/s41419-022-04839-0.
Glucose Metabolism is a Better Marker for Predicting Clinical Alzheimer's Disease than Amyloid or Tau.
Hammond T, Lin A
J Cell Immunol. 2022; 4(1):15-18.
PMID: 35373192
PMC: 8975178.
Diabetes duration and the risk of dementia: a cohort study based on German health claims data.
Reinke C, Buchmann N, Fink A, Tegeler C, Demuth I, Doblhammer G
Age Ageing. 2021; 51(1).
PMID: 34923587
PMC: 8753043.
DOI: 10.1093/ageing/afab231.
Gauging the role and impact of drug interactions and repurposing in neurodegenerative disorders.
Khatri D, Kadbhane A, Patel M, Nene S, Atmakuri S, Srivastava S
Curr Res Pharmacol Drug Discov. 2021; 2:100022.
PMID: 34909657
PMC: 8663985.
DOI: 10.1016/j.crphar.2021.100022.